“I think it’s really important that people keep signing up to these type of trials to push research forward.”
A study looking at a way to check if chemotherapy is working for non Hodgkin lymphoma and Hodgkin lymphoma (BiLD)
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking for substances in the blood that may tell doctors that chemotherapy for non Hodgkin lymphoma and Hodgkin lymphoma is working.
More about this trial
In this study the researchers want to see if they can use substances in the blood (
Who can enter
The researchers need 50 people to join this study. You will give blood samples
- Before starting chemotherapy
- 8 days after starting chemotherapy
- Before each chemotherapy treatment
- At the end of chemotherapy
- Every 3 months for at least 2 years or until your lymphoma comes back
You will also have an
- MRI scan before starting chemotherapy
- MRI scan and a CT scan or PET-CT scan 8 days after starting chemotherapy
- MRI scan 6 to 8 weeks after finishing chemotherapy
The researchers will ask for a sample of your lymphoma that was removed when you had surgery or a
The researchers will also ask you to rinse your mouth with salt water for 30 seconds and then spit it into a container. This is to get a sample of your normal
You see the doctor to have a physical examination before taking part in this study.
You need to make 2 extra visits to the hospital for the scans.
There is a very low risk that you may have an allergic reaction to the injection used for the MRI scans.
Taking part in this study means you will be exposed to some extra radiation during the extra scans. The amount of radiation you will receive is about the same as the average amount of background radiation from 18 years living in England. The trial team will answer any questions you have about this.
How to join a clinical trial
Dr Shireen Kassam
Elimination of Leukaemia Fund
King's College London
Kings College Hospital NHS Foundation Trust
NIHR Clinical Research Network: Cancer